welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- login
Extracellular RNAs in Urine May Work as Biomarker for Duchenne and Myotonic Dystrophy Patients
Extracellular RNAs found in urine may be able to serve as non-invasive biomarkers of how patients with muscular dystrophy — especially those with an adult-onset and the more common Duchenne MD form — are responding to therapy, a study reports.
Urine-sample tests for these RNAs may also lessen the need for invasive approaches like muscle biopsies in these patients and in others with similar diseases.
rareRelated
-
Catabasis Pharmaceuticals Presents Data Supporting MRI T2 as a Potential Marker of Clinical Outcome in Duchenne Musc...Catabasis Pharmaceuticals, Inc. (NASDAQ:...
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic TomographyThis pilot study aims to assess subcellu...
-
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophySerum biomarkers in Duchenne muscular dy...
-
A Prospective Natural History Study of Progression of Subjects With Duchenne Muscular DystrophyTo characterize the natural history and ...
-
Biomarker for Duchenne Disease (BIODUCHENNE)Development of a new mass spectrometry-b...
-
Quantitative EMG in Duchenne Muscular DystrophyObjective: Multi-motor unit analysis (M...
-
Cardiac Magnetic Resonance in Children With Muscular DystrophyThis protocol will exploit novel state o...
-
Myocardial T1 and T2 Mapping in Duchenne muscular dystrophy: characterization of late gadolinium enhancementBackground: In the current era, cardiov...
-
Santhera to present novel data highlighting the clinical relevance of peak expiratory flow as predictor of disease p...Santhera Pharmaceuticals announces that ...
